CVS-Aetna deal won’t necessarily make drugs cheaper — and could even raise prices
CVS Health Corp.’s bid for Aetna Inc., which could be valued at more than $66 billion, would — if successful — combine two businesses that have traditionally been separate, health insurance and pharmacy-benefit management.
